Literature DB >> 9209436

Role of the stem cell factor (SCF) receptor and the alternative forms of its ligand (SCF) in the induction of long-term growth by stroma cells.

J Friel1, C Heberlein, K Itoh, W Ostertag.   

Abstract

Self renewal and differentiation of hematopoietic stem cells is regulated by the hematopoietic microenvironment. The Stem Cell Factor (SCF) has been shown to be one of the essential factors that governs stem cell maintenance. In this abstract we describe a functional analysis of the membrane bound and soluble SCF within the context of stroma cocultures with hematopoietic cells. We report that transmembrane SCF is essential for long term growth, whereas soluble SCF supports only short term proliferation of stroma dependent hematopoietic cells. We also show that the SCF/c-kit interaction can be substituted by an unknown mechanism. To determine the molecular mechanism involved in maintenance of hematopoietic cells on stroma we analyzed the c-kit expression during coculture. We demonstrate that c-kit expression was downregulated during coculture. Downregulation was induced by the coculture itself and not by external factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209436

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Selective deletion of the membrane-bound colony stimulating factor 1 isoform leads to high bone mass but does not protect against estrogen-deficiency bone loss.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Nancy Troiano; Mei-Ling Zhu; Xiao-Yan Xiao; Karl Insogna
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

Review 2.  Signaling pathways influencing SLF and c-kit-mediated survival and proliferation.

Authors:  Stuart A Berger
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Selective deletion of the soluble Colony-Stimulating Factor 1 isoform in vivo prevents estrogen-deficiency bone loss in mice.

Authors:  Gang-Qing Yao; Nancy Troiano; Christine A Simpson; Karl L Insogna
Journal:  Bone Res       Date:  2017-11-14       Impact factor: 13.567

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.